Prostate Cancer Trial, Recruiting (NCT05403177)

Prostate Cancer Trial, Recruiting NCT05403177 Sponsor: University Health Network, Toronto Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05403177 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a blood cancer or a solid tumor (a growth/lump), confirmed by a lab test of a tissue or cell sample
If your type of cancer doesn't usually require a biopsy before surgery to confirm the diagnosis, you may still join, but your eligibility will be confirmed once lab results from your tissue are available
You have existing medical records and test results that meet the minimum data requirements for this study (confirm with trial site for specific details)
You have stored tissue samples and/or blood samples available that can be used for detailed scientific testing
If you don't have enough existing records or stored samples, you may still be able to join by donating a blood sample and/or having a new tissue biopsy taken
You are willing to share your anonymized (identity-removed) medical and genetic data with the research team

Who may not be able to join:

There are no specific exclusion criteria listed for this trial — there are currently no stated reasons that would automatically prevent someone from joining

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lillian Siu, MD, University Health Network, Toronto

Phone: 416-946-4501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05403177

Sponsor: University Health Network, Toronto

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 416-946-4501

More information: https://clinicaltrials.gov/study/NCT05403177

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a blood cancer or a solid tumor (a growth/lump), confirmed by a lab test of a tissue or cell sample
If your type of cancer doesn't usually require a biopsy before surgery to confirm the diagnosis, you may still join, but your eligibility will be confirmed once lab results from your tissue are available
You have existing medical records and test results that meet the minimum data requirements for this study (confirm with trial site for specific details)
You have stored tissue samples and/or blood samples available that can be used for detailed scientific testing
If you don't have enough existing records or stored samples, you may still be able to join by donating a blood sample and/or having a new tissue biopsy taken
You are willing to share your anonymized (identity-removed) medical and genetic data with the research team

Who may not be able to join:

There are no specific exclusion criteria listed for this trial — there are currently no stated reasons that would automatically prevent someone from joining

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Health Network, Toronto

Registry

ClinicalTrials.gov

Start date

23 June 2022

Est. completion

1 April 2030

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Number of patients included in a pan-Canadian cohort with comprehensive clinical and genomic data

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov